Amount of interleukin 12 available at the tumor site is critical for tumor regression.
Year: 1996
Type: article
Source: PubMed
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2149694154
